Product image of Lederlon (Triamcinolone Hexacetonide) supplied by GNH India

Lederlon

Active Ingredient:
Triamcinolone Hexacetonide
Origin:
EU

Lederlon (Triamcinolone Hexacetonide)

Triamcinolone hexacetonide, the active ingredient in Lederlon, is a potent corticosteroid presented as a sterile injection solution for intra‑articular administration. It is used to manage inflammatory joint disorders such as rheumatoid arthritis and osteoarthritis by providing strong anti‑inflammatory and immunosuppressive effects directly within the joint space.

GNH India supplies Lederlon as a licensed, Good Distribution Practice‑compliant pharmaceutical product, providing reliable global sourcing for hospitals, pharmacies, and specialty clinics that require injectable corticosteroids for orthopedic and rheumatologic care through its established logistics network.

Manufacturer / TM Owner

Esteve Pharmaceuticals Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lederlon (triamcinolone hexacetonide) is a corticosteroid used for intra‑articular treatment of inflammatory joint conditions.

  • Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility.
  • Osteoarthritis: alleviates chronic joint swelling and stiffness.
  • Psoriatic arthritis: diminishes synovial inflammation and joint tenderness.
  • Juvenile idiopathic arthritis: provides localized anti‑inflammatory effect to control flare‑ups.
  • Post‑traumatic joint inflammation: limits edema and accelerates functional recovery.

How It Works

  • Triamcinolone hexacetonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses pro‑inflammatory cytokine production, inhibits phospholipase A2, and reduces leukocyte migration, leading to decreased inflammation and immune response within the injected joint.

Side Effects

Lederlon may cause a range of adverse reactions following intra‑articular injection.

Common Side Effects

  • Pain or tenderness at the injection site.
  • Transient flushing or warmth in the treated area.
  • Mild headache or dizziness.
  • Temporary increase in blood glucose levels.
  • Localized bruising or swelling.

Serious or Rare Side Effects

  • Joint infection (septic arthritis).
  • Tendon or ligament rupture.
  • Systemic adrenal suppression.
  • Osteonecrosis of the bone.
  • Severe hyperglycemia or electrolyte imbalance.
  • Anaphylactic or severe allergic reaction.

Precautions & Warnings

Before using Lederlon, consider the following safety measures.

  • Pregnancy: consult a physician; limited safety data are available.
  • Active joint infection: avoid intra‑articular injection in infected joints.
  • Diabetes: monitor blood glucose closely as hyperglycemia may occur.
  • Concurrent systemic steroids: assess cumulative corticosteroid exposure.
  • Anticoagulant therapy: evaluate bleeding risk before injection.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Lederlon can interact with other medicines; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid)

  • Systemic CYP3A4 inhibitors (e.g., ketoconazole): may raise steroid levels.
  • Live vaccines: increased risk of infection due to immunosuppression.
  • Other systemic corticosteroids: additive immunosuppressive effect.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (e.g., warfarin): may enhance anticoagulant effect.
  • NSAIDs: higher chance of gastrointestinal ulceration.
  • Antidiabetic agents: may require dosage adjustment because of steroid‑induced hyperglycemia.

Frequently Asked Questions

Lederlon contains triamcinolone hexacetonide and is administered by intra‑articular injection to treat inflammatory joint disorders such as rheumatoid arthritis, osteoarthritis, and other conditions that cause joint swelling, pain, and reduced mobility.

The drug binds to glucocorticoid receptors inside cells, altering gene expression to suppress pro‑inflammatory cytokines, inhibit leukocyte migration, and reduce the activity of enzymes that generate inflammatory mediators, thereby decreasing joint inflammation.

The dose of Lederlon is determined by the prescribing clinician based on the specific joint, severity of inflammation, patient weight, and overall treatment plan. No standard regimen is provided here; the prescriber sets the appropriate amount.

Safety data for triamcinolone hexacetonide during pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks and discuss options with the patient before use.

To request Lederlon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Lederlon (triamcinolone hexacetonide) offers a longer duration of action compared with shorter‑acting agents such as methylprednisolone acetate. This can reduce the frequency of injections but may also increase the risk of prolonged local side effects. Choice of steroid depends on the clinical scenario and physician preference.

Lederlon should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use to maintain sterility and potency.

Lederlon is given as a sterile intra‑articular injection by a qualified healthcare professional. The medication is injected directly into the affected joint using aseptic technique to ensure accurate delivery and minimize infection risk.

Serious risks include joint infection (septic arthritis), systemic adrenal suppression, osteonecrosis, tendon rupture, severe hyperglycemia, and rare allergic reactions such as anaphylaxis. Patients should be monitored closely for signs of infection or systemic side effects after injection.

Lederlon is contraindicated in patients with active joint infection, known hypersensitivity to triamcinolone hexacetonide or any component of the formulation, uncontrolled systemic fungal infections, and those receiving systemic corticosteroids at high doses where additive effects could be harmful.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triamcinolone Hexacetonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT